Biomoneta earns US-FDA Class II clearance for medical air cleaners

BENGALURU: Biomoneta Research Private Limited, a Bengaluru-based healthtech company, announces it has received US Food and Drug Administration (FDA) 510(k) Class II clearance for the Biomoneta® Avata Rx Medical Recirculating Air Cleaner. The clearance enables Biomoneta to enter the US and healthcare market with its globally patented ZeBox technology.

The Avata Rx system is built on Biomoneta’s proprietary ZeBox platform, which represents a fundamentally different approach to air decontamination compared to conventional systems. Instead of relying…